Edgewise Therapeutics Inc (EWTX)
SG&A Expenses
$14.40M
Quarterly · Period ending: · USD
EWTX SG&A Expenses
Latest reported$14.40Mperiod ending
Latest reported$14.40Mperiod ending
EWTX Quarterly SG&A Expenses ($281.00K → $14.40M)
Quarterly SG&A Expenses
High-resolution chart · PNG
EWTX sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 14,395,000 | |
| 11,464,000 | |
| 12,385,000 | |
| 9,378,000 | |
| 9,052,000 | |
| 9,202,000 | |
| 9,170,000 | |
| 8,210,000 | |
| 7,427,000 | |
| 7,059,000 | |
| 6,178,000 | |
| 5,666,000 | |
| 5,780,000 | |
| 5,828,000 | |
| 5,467,000 | |
| 4,368,000 | |
| 4,089,000 | |
| 3,702,000 | |
| 3,734,000 | |
| 3,196,000 | |
| 2,599,000 | |
| 1,497,000 | |
| 1,205,000 | |
| 405,000 | |
| 318,000 | |
| 281,000 |